Hikma Pharmaceutical | Costo Del Venduto



Cost Of Sales Cambiamento Data
Almirall EUR 16.73M 73.47M 2024-06
argenx SE USD 72.66M 222.35M 2024-12
AstraZeneca USD 2.72B 263M 2024-12
Autolus Therapeutics Ltd 11.39M 11.26M 2024-12
Bayer EUR 5.72B 633M 2024-12
Fresenius EUR 4.22B 212M 2024-12
Galapagos EUR 112.93M 112.91M 2024-12
Genmab DKK 337M 64M 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
GRIFOLS EUR 1.21B 143.12M 2024-12
Hikma Pharmaceutical USD 813M 39M 2024-06
Lonza CHF 1.94B 858M 2024-06
Merck EUR 2.32B 197M 2024-12
Orion EUR 167.1M 15.2M 2024-12
Recordati EUR 172.29M 19.33M 2024-09
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 4.08B 675M 2024-09
UCB EUR 425.5M 479.5M 2024-06



Hikma Pharmaceutical Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.